Heparin sodium can interfere with many links of blood coagulation process, and has anticoagulant effect in vivo and in vitro. It mainly acts on the formation of fibrin, but also reduces platelet aggregation. The consequences involve preventing platelet agglutination and destruction, preventing the formation of thrombin activase, preventing prothrombin from becoming thrombin, inhibiting thrombin, thus preventing fibrinogen from becoming fibrin, and thus playing an anticoagulant role.
Heparin sodium can be used for the prevention and treatment of thromboembolic diseases, such as myocardial infarction, pulmonary embolism, cerebrovascular embolism, peripheral venous thrombosis, etc., can prevent the formation and expansion of thrombosis. It can also be used in the early stage of DIC and other anticoagulation in vivo and in vitro.
Qingdao Jiulong Biomedicine is mainly engaged in the scientific research, production and sales of heparin sodium, chondroitin sulfate sodium, enoxaparin sodium, daheparin sodium, heparin sulfate, delpolysaccharide and other raw materials, which are widely used in the medical field.